Grants and Contributions:
Title:
Formulation, scale up and mechanism of action of a potential broad spectrum anti-viral plant isolate PBG-007
Agreement Number:
968451
Agreement Value:
$237,810.00
Agreement Date:
Feb 1, 2021 - Feb 28, 2023
Description:
This project aims to develop broad spectrum immuno-modulatory Natural Health Product to fight virus infections including COVID-19.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Leduc, Alberta, CA T9E 0Z4
Reference Number:
172-2020-2021-Q4-968451
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
720710318
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 17,810 dollars.
Amendment Date
Jan 13, 2023
Recipient's Operating Name:
PBG BioPharma
Recipient's Legal Name:
PBG BioPharma Inc.
Federal Riding Name:
Edmonton--Wetaskiwin
Federal Riding Number:
48021
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: